Edibles and Alcohol Worsened Simulated Driving Without a Detected Rise in THC Exposure
Greater impairment from combining THC edibles and alcohol did not require a statistically detected increase in circulating THC in a controlled study. Driving effects increased under co-use while the measured cannabinoid pharmacokinetic outcomes did not significantly differ from the corresponding cannabis-only conditions.
A specific sequence of exposure
Twenty-five adults completed seven crossover sessions involving placebo, 10 or 25 mg THC brownies, alcohol alone, or selected combinations. Alcohol dosing began 45 minutes after the brownie and was completed approximately one hour after it.
The combination conditions targeted a breath alcohol concentration of 0.05%. Participants were relatively infrequent cannabis users with prior cannabis–alcohol co-use experience. This design did not test every order of consumption, product or drinking pattern.
Functional effects and drug concentrations answered different questions
The study’s composite simulator driving score generally showed greater impairment with combined exposure than with the same doses of either substance alone. Subjective intoxication also increased in combination conditions.
Whole-blood THC and its measured metabolites increased with THC dose, but the pharmacokinetic comparisons did not detect differences between cannabis alone and the corresponding co-use conditions. Breath alcohol measurements were likewise not significantly altered by cannabis.
A pharmacokinetic null does not mean no interaction
Pharmacokinetics concerns the time course of measured drug exposure. Pharmacodynamic outcomes concern what the drugs do. A more pronounced functional effect can occur without a demonstrated change in the measured concentration curve.
The null comparisons do not prove that every pharmacokinetic parameter was exactly identical or that interactions are impossible in larger samples. They show that the observed functional worsening should not be explained as a proven increase in blood THC within this experiment.
Why timing and measurement matter
The authors identified staggered dosing and cannabis-first administration as possible reasons their pharmacokinetic findings differed from earlier inhaled-cannabis studies. Those explanations remain hypotheses, rather than experimentally isolated mechanisms.
The sample was modest, the formulation was a brownie and driving occurred on a simulator. The results do not supply an individual crash-causation formula or a blood concentration that establishes safety. They show why a case review must examine combined effects even when one drug’s measured exposure does not appear to rise.
Related: Interpreting THC concentration and impairment.
Primary research
Impact of Cannabis Edibles Combined With Alcohol on Driving, Field Sobriety Performance, and Subjective Effects: A Within-Participant Crossover Trial. DOI: 10.1001/jamanetworkopen.2026.9842.
